| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
![]()
Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil ...7thSpace Interactive (press release) - Nov 22, 2009 ... (cis-diammine-glycolatoplatinum) and continuous infusion of 5-fluorouracil (5-FU) with radiation in patients with esophageal squamous cell carcinoma. ... Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 ...PR Newswire (press release) - Nov 17, 2009 Genentech/Roche: UK's NICE remains negative over Avastin for colorectal cancerPipelineReview.com (press release) - 8 hours ago The drug was approved in the US in 2004 and the EU in 2005 for first-line metastatic CRC in combination with 5-fluorouracil-based chemotherapy. ... Today's Top Biotechnology Stocks were PARD, CTIC, VVUS : by Penny Stock Pick AlertEmailwire - Nov 18, 2009 Oceanside Pharmaceuticals launches generic LibraxTrading Markets (press release) - Nov 26, 2009 Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced ...7thSpace Interactive (press release) - Nov 3, 2009 A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-acting release (LAR) octreotide in patients with ... Breast Cancer Regimen Effective But ToxicMedPage Today - - Nov 10, 2009 Capecitabine is a prodrug of fluorouracil, and the final step in the conversion to fluorouracil is catalyzed by thymidine phosphorylase, which is elevated ... Amgen: Vectibix disappoints in colorectal cancer but hope remainsTrading Markets (press release) - Nov 6, 2009 Results from the recent Phase III CRYSTAL trial evaluating Erbitux in combination with FOLFIRI (folinic acid, fluorouracil, irinotecan) demonstrated that ... Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced ...DG News - Nov 24, 2009 A total of 109 patients were randomly assigned to treatment with cetuximab plus oxaliplatin, fluorouracil, and folinic acid (FOLFOX6; group A) or cetuximab ... Poniard's Fortunes Likely Rest on PicoplatinGenetic Engineering News (press release) - Nov 25, 2009 The study results showed that the drug, given once every four weeks in combination with 5-fluorouracil and leucovorin in the FOLPI regimen, has comparable ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests... Bernard von NotHaus (Liberty Dollar) Aubrey de Grey, PhD Dr. Amanuel Sima, MD Dr. Bard Levey, DDS Neal Adams Robin Scovill (director) Richard Diaz (author) Dr. Kaayla T. Daniel, CCN Chana de Wolf, (cryonics researcher) Dr. Mary Ruwart (author & scientist) Richard Diaz (author) Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |